it's still really early work for a company listed 10 years - you'll always struggle to find investor interest on animal studies and proof of concept. The value really comes if big pharma wants to buy into it and either acquires the company or a candidate or puts a deal commensurate on the table. I can't see investors getting to excited and moving price a lot no matter what kind of "holy grail" cancer line you pull on animal studies and POC alone - it needs a pharma to put the value for them to follow - they do occasionally pay up big for pre-clinical and POC but it wont be the market alone that will do it. Still flipping coins imv.
PYC Price at posting:
1.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)